| Medical Condition | Chronic Cough |
| Facility/Clinic | Accellacare – 1222 Medical Center Dr |
| Age | 18-80 years old |
| Gender | Male & Female |
| Description | A phase 3, 52-week, randomized, efficacy and safety study with open-label extension of BLU-5937 in adult participants with refractory or unexplained chronic cough. |
| Enrollment | Open |
| Patient Commitment Duration | 18 months |
| Number of visits in study | 25 |
| Patient Compensation | $50-$100/visit (varies per visit) |
The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial.
Please call 910-799-5500 between the hours of 8am-5pm for general research questions.